Skip to main content

Orthogon Therapeutics

Canton, United States

Orthogon Therapeutics is a drug development company developing antiviral drugs for immune-suppressed patients.

$5.2M raised
Apr 2026
Undisclosed

Top Investors

Over-the-Rhine VenturesHolbrook Angels of Boston

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Orthogon Therapeutics

How much funding has Orthogon Therapeutics raised?
Orthogon Therapeutics has raised $5.2M in total funding. The most recent round was Undisclosed. The last funding was announced in April 2026.
Who are Orthogon Therapeutics's investors?
Orthogon Therapeutics's investors include Over-the-Rhine Ventures, Holbrook Angels of Boston.
Where is Orthogon Therapeutics headquartered?
Orthogon Therapeutics is headquartered in Canton, United States.
What does Orthogon Therapeutics do?
Orthogon Therapeutics is a drug development company developing antiviral drugs for immune-suppressed patients.
What stage is Orthogon Therapeutics at?
Orthogon Therapeutics is at the Undisclosed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Orthogon Therapeutics — Funding & Investors." VCBacked, April 17, 2026, https://www.vcbacked.co/company/orthogon-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2026). Orthogon Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/orthogon-therapeutics
Wikipedia (cite web)
{{cite web |title=Orthogon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/orthogon-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .